Dernières nouvelles concernant le Syndrome Prader-Willi
-
Rare Disease Spotlight: Prader-Willi pipeline remains centered on obesity management - biocentury.com
Wed, 27 Aug 2025 21:15:00 GMT
-
Soleno Therapeutics responds to short seller’s Prader-Willi drug safety claims - statnews.com
Thu, 21 Aug 2025 10:31:12 GMT
-
Long-term impact of growth hormone therapy on mortality and type 2 diabetes in Prader–Willi syndrome: a nationwide cohort study - Frontiers
Thu, 21 Aug 2025 07:00:00 GMT
-
New hope for Prader-Willi hunger as Phase 3 trial expands - Prader-Willi Syndrome News
Thu, 31 Jul 2025 19:56:32 GMT
-
Molecular characterization of imprinting disorders: Beckwith–Wiedemann, Silver–Russell, and Prader-Willi syndromes in Egyptian patients - BMC Pediatrics
Tue, 29 Jul 2025 07:00:00 GMT
-
Nearly all Prader-Willi syndrome patients hospitalized in childhood - Prader-Willi Syndrome News
Thu, 24 Jul 2025 16:33:10 GMT
-
Finding friends is challenging for those with Prader-Willi syndrome - Prader-Willi Syndrome News
Mon, 21 Jul 2025 07:00:00 GMT
-
Prader-Willi patients in Japan see benefits with somatropin treatment - Prader-Willi Syndrome News
Thu, 10 Jul 2025 07:00:00 GMT
-
How we foster independence in our son with Prader-Willi syndrome - Prader-Willi Syndrome News
Fri, 04 Jul 2025 07:00:00 GMT
-
Mechanism of EHMT2-mediated genomic imprinting associated with Prader-Willi syndrome - Nature
Thu, 03 Jul 2025 07:00:00 GMT
Copyrights :
Feed from : Copyright © 2025 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.
Module from : ©2013 CAPRICE - IT Services. Tous droits réservés.
Feed from : Copyright © 2025 Google. All rights reserved. This XML feed is made available solely for the purpose of rendering Google News results within a personal feed reader for personal, non-commercial use. Any other use of the feed is expressly prohibited. By accessing this feed or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.
Module from : ©2013 CAPRICE - IT Services. Tous droits réservés.